NEW YORK (TheStreet) -- CHANGE IN RATINGS
upgraded at Argus. APD was upgraded from Hold to Buy. $94 price target. Company should benefit from stronger global economic activity.
upgraded at BofA/Merrill to Buy from Neutral. Valuation call. Price target increased to $70 from $64.
upgraded at UBS from Sell to Neutral. Valuation call, based on $84 price target. Estimates also boosted, because of a better natural gas outlook.
downgraded at MKM from Buy to Neutral. Valuation call, as the stock is up 32% year-to-date. $29 price target.
initiated at BofA/Merrill. EFX coverage initiated at Bank of America/Merrill Lynch with a Neutral rating and $38 price target. Cyclical tailwinds factored in.
ITT Educational Services
downgraded at Credit Suisse to Neutral from Outperform. Weak guidance and lower-than-expected earnings. Price target sunk to $110 from $135.
downgraded at Collins Stewart. FITB was downgraded from Buy to Hold. Valuation call.
First Midwest Bancorp
downgraded at Oppenheimer from Outperform to Perform. Valuation call, even though the company delivered strong first quarter results.
upgraded at Goldman from Sell to Neutral. $41 price target. Estimates also boosted, given higher BPO margins and improving consulting demand.
upgraded at Stifel from Hold to Buy. Lodging recovery is underway and the company can leverage its real estate platform. $70 price target.
target, estimates boosted at Barclays. JCI price target lifted by a dollar to $36 after 2Q10 beat. 2010 and 2011 EPS estimates raised to $2 and $2.60, respectively. Equal Weight rating.
upgraded at Baird from Neutral to Outperform. $42 price target. Company has strong growth potential in China and should see a rapid recovery in margins.
upgraded at Barclays to Overweight from Equal Weight on improving trends in the company's customer base. Price target raised by a dollar to $27. 2010 and 2011 EPS estimates held at $0.77 and $0.95, respectively.
downgraded at BMO from Outperform to Market Perform. Valuation call, based on a $17 price target.
downgraded at Suntrust from Outperform to Market Perform. Valuation call, even though the company had a solid first quarter.
upgraded at BofA/Merrill to Buy from Neutral as the industrial economy has entered an expansion phase that can be sustained. Price target surged to $87 from $58.
upgraded at UBS. SYY was upgraded from Neutral to Buy. $37 price target. Estimates also raised, because of improving restaurant trends.
upgraded at Jefferies from Hold to Buy. $62 price target. Company should benefit from industrial recovery.
downgraded at KBW from Outperform to Market Perform. Valuation call, based on a $28 price target.
Total System Services
initiated at BofA/Merrill with an Underperform rating and $16 price target. Persistent headwinds. EPS growth could resume in 2011.
rated new Buy at MKM Partners. $80 price target. Company should deliver significant free cash flow growth over the next two years.
upgraded at JP Morgan. Rating raised to Overweight from Neutral. Price target raised to $70 from $68. Maintains 2010 EPS estimates of $4.27.
STOCK COMMENTS / EPS CHANGES
price target trimmed at Barclays to $17 from $18 on concerns over Chrysler relationship. AONE could likely receive DOE funding soon. Equal Weight rating.
numbers boosted at Goldman. Shares of AXP now seen reaching $50. Estimates also upped, because of improving credit and cost trends. Neutral rating.
estimates cut at Morgan Stanley through 2012. Troponin should weigh on earnings and the company is spending more on quality control. Equal-weight rating.
estimates boosted at UBS through 2011. Company should see sales recover, with the sales halt removed. Buy rating and $8 price target.
estimates, target boosted at Morgan Stanley. BUCY estimates were upped through 2011. Channel checks suggest better mining results. Overweight rating and new $80 price target.
numbers upped at UBS. CAH estimates were boosted through 2011. Company should benefit from a strong generic drug pipeline. Buy rating and new $43 price target.
numbers raised at Oppenheimer. Shares of CSCO now seen reaching $32. Estimates also increased, following positive channel checks. Outperform rating.
price target boosted at BofA/Merrill. DG price target raised to $36 from $30 on consistent execution and growth prospects. Reiterate Buy rating.
estimates, target upped at Morgan Stanley. Shares of DOV now seen reaching $63. Company is seeing higher order trends and deserves a higher multiple. Overweight rating.
estimates raised at Goldman. GLW estimates were increased through 2012. Inventory remains tight in the LCD supply chain. Buy rating.
Hudson City Bancorp
numbers lowered at FBR. HCBK estimates were cut through 2011. Company is seeing slower balance sheet growth. Outperform rating and new $15 price target.
estimates, target raised at UBS. Shares of HON now seen reaching $47. Estimates also increased, given better end-market demand and M&A opportunities. Neutral rating.
numbers raised at Morgan Stanley. Shares of IR now seen reaching $38. Estimates also increased, given stronger orders. Equal-weight rating.
numbers lowered at Goldman. Estimates were cut through 2012. Company will likely faces rising costs. Neutral rating and new $50 price target.
estimates, target increased at Goldman. NKE estimates were raised through 2012. Company likely to talk up accelerating growth trends at its upcoming investor meeting. Buy rating and new $85 price target.
price target raised at BofA/Merrill. ORLY price target lifted to $52 from $46 as 1Q10 is expected to benefit from early spring and DC progress. Maintain Buy rating.
numbers boosted at Goldman. Shares of PCX now seen reaching $25. Estimates also upped, given the company's new production guidance and lower expected costs. Sell rating.
estimates, target upped at Goldman. RTN estimates were boosted through 2012. Company will likely repurchase more shares. Neutral rating and new $52 price target.
target, estimates boosted at Citi. SLB price target jumped to $92 from $84 as the international recovery is ahead of expectations. 2010 and 2011 EPS estimates lifted to $2.95 and $3.65, respectively. Maintain Buy rating.
target, estimates cut at Barclays. VZ price target lowered a dollar to $32 on expected lower wireline margins. 2010 and 2011 EPS estimates sunk to $2.14 and $2.31, respectively. Maintain Equal Weight rating.
numbers increased at FBR. Shares of WBS now seen reaching $18. Estimates also raised, given lower credit costs. Market Perform rating.
estimates, target increased at UBS. Shares of WCC now seen reaching $47. Estimates also raised, as the company is seeing higher industrial sales and is paying down debt. Buy rating.
This article was written by a staff member of TheStreet.com.